Additional file 4 of Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
posted on 2022-06-16, 09:47authored byGremese Elisa, Barbara Tolusso, Luca Petricca, Clara Di Mario, Maria Rita Gigante, Gianfranco Ferraccioli, Stefano Alivernini
Additional file 4: Supplementary Fig. 3. IL-6 serum levels (A) and peripheral blood CD4posCD25posFoxP3high subset distribution (B) across 12 months follow-up in RA patients treated with CTLA4-Ig based on the achievement of DAS-remission.